Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-26-000315
Filing Date
2026-01-02
Accepted
2026-01-02 13:15:02
Documents
20
Effectiveness Date
2026-01-02

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0271168-s8_ydbio.htm S-8 57879
2 OPINION OF OGIER ea027116801ex5-1_ydbio.htm EX-5.1 40289
3 YD BIO LIMITED EQUITY INCENTIVE PLAN ea027116801ex10-1_ydbio.htm EX-10.1 58517
4 CONSENT OF CBIZ CPAS P.C ea027116801ex23-2_ydbio.htm EX-23.2 1704
5 CONSENT OF MARCUM LLP ea027116801ex23-3_ydbio.htm EX-23.3 1783
6 CONSENT OF ARK PRO CPA & CO ea027116801ex23-4_ydbio.htm EX-23.4 2970
7 FILING FEE TABLE ea027116801ex-fee_ydbio.htm   iXBRL EX-FILING FEES 13161
8 GRAPHIC ex5-1_001.jpg GRAPHIC 5319
9 GRAPHIC ex23-4_001.jpg GRAPHIC 13555
10 GRAPHIC ex23-4_002.jpg GRAPHIC 9408
  Complete submission text file 0001213900-26-000315.txt   336936

Data Files

Seq Description Document Type Size
22 EXTRACTED XBRL INSTANCE DOCUMENT ea027116801ex-fee_ydbio_htm.xml XML 5121
Mailing Address 955 WEST JOHN CARPENTER FREEWAY SUITE 100-929 IRVING TX 75039
Business Address 955 WEST JOHN CARPENTER FREEWAY SUITE 100-929 IRVING TX 75039 619-500-7747
YD Bio Ltd (Filer) CIK: 0002011674 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-292554 | Film No.: 26501477
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)